Company

SQZ Biotechnologies Company

Headquarters: Watertown, MA, United States

Employees: 98

CEO: Dr. Armon R. Sharei Ph.D.

NYSE: SQZ +1.06%

Market Cap

$25.7 Million

USD as of Jan. 1, 2023

Market Cap History

SQZ Biotechnologies Company market capitalization over time

Evolution of SQZ Biotechnologies Company market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of SQZ Biotechnologies Company

Detailed Description

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

SQZ Biotechnologies Company has the following listings and related stock indices.


Stock: NYSE: SQZ wb_incandescent

Details

Headquarters:

200 Arsenal Yards Boulevard

Suite 210

Watertown, MA 02472

United States

Phone: 617 758 8672